Market Research Logo

EyePoint Pharmaceuticals Inc (PSDV) - Product Pipeline Analysis, 2018 Update

Summary

EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, used for the treatment of chronic diseases of the back of the eye. EyePoint’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company provides drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. It operates in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company EyePoint Pharmaceuticals Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


EyePoint Pharmaceuticals Inc Company Overview
EyePoint Pharmaceuticals Inc Company Snapshot EyePoint Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview EyePoint Pharmaceuticals Inc – Pipeline Analysis Overview EyePoint Pharmaceuticals Inc - Key Facts EyePoint Pharmaceuticals Inc - Major Products and Services EyePoint Pharmaceuticals Inc Pipeline Products by Development Stage EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status EyePoint Pharmaceuticals Inc Pipeline Products Overview Durasert - Back Of Eye Disease Durasert - Back Of Eye Disease Product Overview Durasert - Front Of Eye Disease Durasert - Front Of Eye Disease Product Overview Durasert - Knee Osteoarthritis Durasert - Knee Osteoarthritis Product Overview Durasert Latanoprost Implant Durasert Latanoprost Implant Product Overview DURASERT With TKI - Wet AMD DURASERT With TKI - Wet AMD Product Overview Next Gen Duraset - Posterior Segment Uveitis Next Gen Duraset - Posterior Segment Uveitis Product Overview Tethadur System Tethadur System Product Overview YUTIQ YUTIQ Product Overview YUTIQ Clinical Trial EyePoint Pharmaceuticals Inc - Key Competitors EyePoint Pharmaceuticals Inc - Key Employees EyePoint Pharmaceuticals Inc - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Recent Developments EyePoint Pharmaceuticals Inc, Recent Developments Jul 11, 2018: EyePoint Pharmaceuticals Announces Data Highlighting YUTIQ for Posterior Segment Uveitis to be Presented at the 36th Annual Scientific Meeting of the American Society of Retina Specialists Jul 10, 2018: BioArctic receives regulatory approval in Finland for Phase 1/2 study in patients with Complete Spinal Cord Injury Jun 26, 2018: EyePoint Pharmaceuticals Names Goran Ando As Board Director May 16, 2018: EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S. May 08, 2018: EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results Apr 18, 2018: EyePoint Pharmaceuticals YUTIQ for Posterior Segment Uveitis to be Presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting Mar 19, 2018: pSivida Announces FDA Acceptance For Filing of New Drug Application (NDA) for Durasert Three-Year Treatment for Posterior Segment Uveitis Feb 07, 2018: pSivida Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines Feb 07, 2018: pSivida's Second Phase 3 Study for Durasert Three-year Treatment for Posterior Segment Uveitis Maintains Positive Efficacy and Safety Profile at 12 Months Jan 08, 2018: pSivida Submits New Drug Application for Durasert Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA
Appendix
Methodology About GlobalData Contact Us Disclaimer
List of Tables
EyePoint Pharmaceuticals Inc Pipeline Products and Ongoing Clinical Trials Overview
EyePoint Pharmaceuticals Inc Pipeline Products by Equipment Type
EyePoint Pharmaceuticals Inc Pipeline Products by Indication
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status
EyePoint Pharmaceuticals Inc, Key Facts
EyePoint Pharmaceuticals Inc, Major Products and Services
EyePoint Pharmaceuticals Inc Number of Pipeline Products by Development Stage
EyePoint Pharmaceuticals Inc Pipeline Products Summary by Development Stage
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials Summary
Durasert - Back Of Eye Disease - Product Status
Durasert - Back Of Eye Disease - Product Description
Durasert - Front Of Eye Disease - Product Status
Durasert - Front Of Eye Disease - Product Description
Durasert - Knee Osteoarthritis - Product Status
Durasert - Knee Osteoarthritis - Product Description
Durasert Latanoprost Implant - Product Status
Durasert Latanoprost Implant - Product Description
DURASERT With TKI - Wet AMD - Product Status
DURASERT With TKI - Wet AMD - Product Description
Next Gen Duraset - Posterior Segment Uveitis - Product Status
Next Gen Duraset - Posterior Segment Uveitis - Product Description
Tethadur System - Product Status
Tethadur System - Product Description
YUTIQ - Product Status
YUTIQ - Product Description
YUTIQ - A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
YUTIQ - A Phase III, Multi-national, Multi-center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
EyePoint Pharmaceuticals Inc, Key Employees
EyePoint Pharmaceuticals Inc, Subsidiaries
Glossary
List of Figures
EyePoint Pharmaceuticals Inc Pipeline Products by Equipment Type
EyePoint Pharmaceuticals Inc Pipeline Products by Development Stage
EyePoint Pharmaceuticals Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report